等待开盘 08-16 09:30:00 美东时间
+2.190
+1.44%
WideOpenWest (NYSE:WOW) will release its quarterly earnings report on Monday, 2...
08-09 03:03
Cabaletta Bio announced plans to initiate registration cohorts for rese-cel in myositis by late 2025 and anticipates a 2027 BLA submission. Five disease-specific cohorts in the RESET program have completed enrollment, with expansion ongoing across multiple autoimmune diseases. The company also highlighted positive clinical data at the EULAR 2025 Congress, showing significant patient responses without immunomodulators or steroids. Furthermore, the...
08-07 11:30
Cabot Corporation has agreed to acquire Mexico Carbon Manufacturing (MXCB) from Bridgestone Corporation for $70 million. The facility, operational since 2005, will enhance Cabot's reinforcing carbon production and strengthen its partnership with Bridgestone. The acquisition aligns with Cabot's strategy to expand core markets and support long-term growth. The deal is subject to regulatory approval and expected to close within three to six months.
08-04 20:30
Wells Fargo analyst Steven Cahall maintains Cable One (NYSE:CABO) with a Underweight and lowers the price target from $210 to $120.
08-01 22:39
EchoStar (NASDAQ:SATS) is gearing up to announce its quarterly earnings on Frid...
08-01 01:02
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Comcast (NASDAQ:CMCSA) will release its quarterly earnings report on Thursday, ...
07-30 22:02
Cabot Corporation launches LITX 95F, a conductive carbon additive for lithium-ion batteries in energy storage systems (ESS), enhancing conductivity, cycle life, and processability for residential, commercial, and industrial applications. The product addresses the growing demand for reliable energy storage amid the shift to renewable energy and grid flexibility, offering improved cycle life, energy density, and cost efficiency. Jeff Zhu, EVP and P...
07-29 13:00
– Approval is based on the phase 3 CABINET pivotal trial, in which CABOMETYX demonstrated a statistically significant and clinically meaningful improvement in progression-free survival versus placebo –– CABOMETYX is the
07-25 05:05
Cabot Corporation declared a quarterly dividend of $0.45 per share on all outstanding shares of its common stock. The dividend will be paid on September 11, 2025, to stockholders of record as of August 29, 2025. Cabot Corporation is a global leader in specialty chemicals and performance materials, providing products like reinforcing carbons, battery materials, and aerogels.
07-11 21:00